multiple sclerosis (relapsing remitting)

Showing 1 - 2 of 2

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Sclerosis (Relapsing Remitting) Trial (fingolimod, Placebo (6mos) + open label fingolimod (6 mos))

Withdrawn
  • Multiple Sclerosis (Relapsing Remitting)
  • fingolimod
  • Placebo (6mos) + open label fingolimod (6 mos)
  • (no location specified)
Apr 20, 2017

Multiple Sclerosis (Relapsing Remitting) Trial in Aarhus C (Training)

Completed
  • Multiple Sclerosis (Relapsing Remitting)
  • Training
  • Aarhus C, Denmark
  • +1 more
Dec 1, 2014